NeuroPace Announces Participation at Two Upcoming Healthcare Investor Conferences

Company Participation in Conferences - NeuroPace, Inc. will participate in two healthcare investor conferences in September 2024 [1][2] - The first conference is the Lake Street Big8 Best Ideas Growth Conference on September 12th in New York, where management will host one-on-one meetings with investors [2] - The second conference is the Cantor Global Healthcare Conference from September 17th-19th in New York, featuring a fireside chat with CEO Joel Becker and CFO Rebecca Kuhn on September 18th at 11:30am ET [2] Company Overview - NeuroPace is a medical device company based in Mountain View, California, focused on transforming the lives of people living with epilepsy by reducing or eliminating seizures [3] - The company’s RNS System is the first and only commercially available brain-responsive platform that delivers personalized, real-time treatment at the seizure source [3] - This platform aims to improve the standard of care for patients with drug-resistant epilepsy and has potential applications for other brain disorders [3]